JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB40761

Anti-CEBP Alpha/CEBPA antibody [EP708Y]

4

(2 Reviews)

|

(27 Publications)

Rabbit Recombinant Monoclonal CEBP Alpha/CEBPA antibody. Suitable for ChIC/CUT&RUN-seq, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 27 publications.

View Alternative Names

CEBP, CEBPA, CCAAT/enhancer-binding protein alpha, C/EBP alpha

7 Images
Flow Cytometry (Intracellular) - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)

Overlay histogram showing HeLa cells stained with ab40761 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab40761, 1/100 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.

Immunocytochemistry/ Immunofluorescence - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)

ab40761 (1/250) staining HeLa cells using immunofluorescence.

Western blot - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)
  • WB

AbReview29648****

Western blot - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)

Blocked with 5% Milk for 1 hour at 24°C.

We are unsure as to the identity of the 30kda band.

All lanes:

Western blot - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (ab40761) at 1/5000 dilution

All lanes:

Human MCF-7 whole cell lysate at 100000 Cells

Secondary

All lanes:

HRP-conjugated Donkey anti-rabbit IgG polyclonal at 1/2000 dilution

Predicted band size: 38 kDa

Observed band size: 40 kDa

true

Exposure time: 1min

This image is courtesy of an anonymous Abreview

Western blot - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)
  • WB

Unknown

Western blot - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)

We are unsure as to the identity of the 30kda band.

All lanes:

Western blot - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (ab40761) at 1/1000 dilution

All lanes:

U937 + LPS cell lysate at 10 µg

Predicted band size: 38 kDa

Observed band size: 30 kDa,43 kDa

false

ChIC/CUT&RUN sequencing - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)
  • ChIC/CUT&RUN-seq

Lab

ChIC/CUT&RUN sequencing - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)

ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 THP-1 (human monocytic leukemia monocyte) cells and 5 µg of ab40761 [EP708Y]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.

The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.

ChIC/CUT&RUN sequencing - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)
  • ChIC/CUT&RUN-seq

Lab

ChIC/CUT&RUN sequencing - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)

ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 THP-1 (human monocytic leukemia monocyte) cells and 5 µg of ab40761 [EP708Y]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.

The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) method

ChIC/CUT&RUN sequencing - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)
  • ChIC/CUT&RUN-seq

Lab

ChIC/CUT&RUN sequencing - Anti-CEBP Alpha/CEBPA antibody [EP708Y] (AB40761)

ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 THP-1 (human monocytic leukemia monocyte) cells and 5 µg of ab40761 [EP708Y]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.

The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.

  • Carrier free

    Anti-CEBP Alpha/CEBPA antibody [EP708Y] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP708Y

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF, WB, Flow Cyt (Intra), ChIC/CUT&RUN-seq

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody recognizes isoform1 and isoform 4.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ChICCUTRUNseq" : {"fullname" : "ChIC/CUT&RUN sequencing", "shortname":"ChIC/CUT&RUN-seq"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "IHC" : {"fullname" : "Immunohistochemistry", "shortname":"IHC"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ChICCUTRUNseq-species-checked": "testedAndGuaranteed", "ChICCUTRUNseq-species-dilution-info": "", "ChICCUTRUNseq-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "IHC-species-checked": "notRecommended", "IHC-species-dilution-info": "", "IHC-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/250 - 1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/100", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" } } }

Product details

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine, 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CEBP Alpha also known as CEBPA is a transcription factor belonging to the CCAAT/enhancer-binding protein family. It is composed of a molecular mass approximately between 42 to 45 kDa and is characterized by the leucine zipper motif which contributes to its function in dimerization and DNA binding. CEBP Alpha is expressed in various tissues with notable expression in the liver adipose tissue and hematopoietic cells where it plays a significant role in regulating gene expression related to growth arrest and differentiation.
Biological function summary

CEBP Alpha regulates important cellular processes by acting as a transcriptional regulator. It participates in the control of cellular differentiation proliferation and metabolism. CEBP Alpha forms homo- or heterodimers with other proteins of the CEBP family to exert its functions. It induces expression of genes involved in differentiation of myeloid progenitors into granulocytes and macrophages. The protein also promotes adipogenesis by activating genes responsible for the development and function of adipocytes.

Pathways

CEBP Alpha participates actively in signaling pathways that involve cell cycle control and hematopoiesis. In the hematopoietic pathway CEBP Alpha influences the differentiation of progenitor cells into mature blood cells. Additionally it interacts with other proteins such as PU.1 an important regulator in the myeloid lineage and through the MAPK pathway influences growth arrest and differentiation responses. These interactions highlight its essential role in maintaining the balance between cell proliferation and differentiation.

Alterations in the function or expression of CEBP Alpha have consequential links to acute myeloid leukemia (AML) and obesity. Mutations or disruptions in the CEBP Alpha gene can lead to impaired granulocyte differentiation contributing to the pathogenesis of AML. Additionally CEBP Alpha through its role in adipogenesis is associated with metabolic disorders such as obesity. The protein's interaction with other transcription factors like FLT3 and GATA-2 in the context of these diseases highlights its critical involvement in maintaining normal physiological functions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcription factor that coordinates proliferation arrest and the differentiation of myeloid progenitors, adipocytes, hepatocytes, and cells of the lung and the placenta. Binds directly to the consensus DNA sequence 5'-T[TG]NNGNAA[TG]-3' acting as an activator on distinct target genes (PubMed : 11242107). During early embryogenesis, plays essential and redundant functions with CEBPB. Essential for the transition from common myeloid progenitors (CMP) to granulocyte/monocyte progenitors (GMP). Critical for the proper development of the liver and the lung (By similarity). Necessary for terminal adipocyte differentiation, is required for postnatal maintenance of systemic energy homeostasis and lipid storage (By similarity). To regulate these different processes at the proper moment and tissue, interplays with other transcription factors and modulators. Down-regulates the expression of genes that maintain cells in an undifferentiated and proliferative state through E2F1 repression, which is critical for its ability to induce adipocyte and granulocyte terminal differentiation. Reciprocally E2F1 blocks adipocyte differentiation by binding to specific promoters and repressing CEBPA binding to its target gene promoters. Proliferation arrest also depends on a functional binding to SWI/SNF complex (PubMed : 14660596). In liver, regulates gluconeogenesis and lipogenesis through different mechanisms. To regulate gluconeogenesis, functionally cooperates with FOXO1 binding to IRE-controlled promoters and regulating the expression of target genes such as PCK1 or G6PC1. To modulate lipogenesis, interacts and transcriptionally synergizes with SREBF1 in promoter activation of specific lipogenic target genes such as ACAS2. In adipose tissue, seems to act as FOXO1 coactivator accessing to ADIPOQ promoter through FOXO1 binding sites (By similarity).. Isoform 3. Can act as dominant-negative. Binds DNA and have transctivation activity, even if much less efficiently than isoform 2. Does not inhibit cell proliferation (PubMed : 14660596).. Isoform 4. Directly and specifically enhances ribosomal DNA transcription interacting with RNA polymerase I-specific cofactors and inducing histone acetylation.
See full target information CEBPA

Publications (27)

Recent publications for all applications. Explore the full list and refine your search

Cell death discovery 11:166 PubMed40216750

2025

MGP regulates the adipogenic differentiation of mesenchymal stem cells in osteoporosis via the Ca2+/CaMKII/RIP140/FABP3 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Xinglang Wang,Yunhui Zhang,Chenhao Xu,Quanfeng Li,Pengfei Ji,Huatao Liu,Yibin Zhang,Jiahao Jin,Zihao Yuan,Miao Yuan,Pei Feng,Yanfeng Wu,Wenjie Liu,Huiyong Shen,Peng Wang

Journal of orthopaedic surgery and research 20:260 PubMed40069718

2025

Therapeutic potential of total flavonoids of Rhizoma Drynariae: inhibiting adipogenesis and promoting osteogenesis via MAPK/HIF-1α pathway in primary osteoporosis.

Applications

Unspecified application

Species

Unspecified reactive species

Hui Su,Luyao Liu,Zechen Yan,WenXuan Guo,Guangxin Huang,Rujie Zhuang,Yu Pan

Cell reports methods 4:100778 PubMed38749443

2024

Modeling alcohol-associated liver disease in humans using adipose stromal or stem cell-derived organoids.

Applications

Unspecified application

Species

Unspecified reactive species

Guoyun Bi,Xuan Zhang,Weihong Li,Xin Lu,Xu He,Yaqiong Li,Rixing Bai,Haiyan Zhang

Cells 13: PubMed38667324

2024

The Role of -Adrenergic Receptors in Cold-Induced Beige Adipocyte Production in Pigs.

Applications

Unspecified application

Species

Unspecified reactive species

Shuo Yang,Hong Ma,Liang Wang,Fang Wang,Jiqiao Xia,Dongyu Liu,Linlin Mu,Xiuqin Yang,Di Liu

Molecular medicine reports 28: PubMed37449516

2023

METTL14 mediates ma modification on osteogenic proliferation and differentiation of bone marrow mesenchymal stem cells by regulating the processing of pri-miR-873.

Applications

Unspecified application

Species

Unspecified reactive species

Xin Dong,Bo Liao,Jian Zhao,Xiaoxiang Li,Kang Yan,Kun Ren,Xiaoping Zhang,Xiaoming Bao,Weidong Guo

International journal of molecular sciences 23: PubMed36361730

2022

Coapplication of Magnesium Supplementation and Vibration Modulate Macrophage Polarization to Attenuate Sarcopenic Muscle Atrophy through PI3K/Akt/mTOR Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Can Cui,Zhengyuan Bao,Simon Kwoon-Ho Chow,Ronald Man Yeung Wong,Ailsa Welch,Ling Qin,Wing Hoi Cheung

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 55:e11741 PubMed35976267

2022

High expression of P4HA3 in obesity: a potential therapeutic target for type 2 diabetes.

Applications

Unspecified application

Species

Unspecified reactive species

Langen Zhuang,Can Li,Xiaolei Hu,Qingqing Yang,Xiaoyan Pei,Guoxi Jin

Organogenesis 18:2061263 PubMed35435152

2022

Hepatocyte Differentiation from iPSCs or MSCs in Decellularized Liver Scaffold: Cell-ECM Adhesion, Spatial Distribution, and Hepatocyte Maturation Profile.

Applications

Unspecified application

Species

Unspecified reactive species

Radiana Dhewayani Antarianto,Adrian Pragiwaksana,Wahyunia Likhayati Septiana,Nuzli Fahdia Mazfufah,Ameer Mahmood

Oxidative medicine and cellular longevity 2021:8528239 PubMed34725565

2021

Dihydrolycorine Attenuates Cardiac Fibrosis and Dysfunction by Downregulating Runx1 following Myocardial Infarction.

Applications

Unspecified application

Species

Unspecified reactive species

Tingjuan Ni,Xingxiao Huang,Sunlei Pan,Zhongqiu Lu

Aging 13:18257-18273 PubMed34311444

2021

The lncRNA H19/miR-541-3p/Wnt/β-catenin axis plays a vital role in melatonin-mediated osteogenic differentiation of bone marrow mesenchymal stem cells.

Applications

Unspecified application

Species

Unspecified reactive species

Hui Han,Tingyu Tian,Guoqian Huang,Dalu Li,Shimao Yang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com